000			01941 a2200529 4500
005			20250515182018.0
264		0	_c20090930
008			200909s 0 0 eng d
022			_a1742-4658
024	7		_a10.1111/j.1742-4658.2009.07165.x _2doi
040			_aNLM _beng _cNLM
100	1		_aLiu, Jinghua
245	0	0	_aAdvanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB. _h[electronic resource]
260			_bThe FEBS journal _cAug 2009
300			_a4598-606 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aActive Transport, Cell Nucleus
650	0	4	_aChemokines _xbiosynthesis
650	0	4	_aCytokines _xbiosynthesis
650	0	4	_aDrug Synergism
650	0	4	_aEndothelial Cells _xmetabolism
650	0	4	_aEndothelium, Vascular _xcytology
650	0	4	_aGlycation End Products, Advanced _xpharmacology
650	0	4	_aHumans
650	0	4	_aInflammation Mediators _xmetabolism
650	0	4	_aLipopolysaccharides _xpharmacology
650	0	4	_aMitogen-Activated Protein Kinases _xmetabolism
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aPhosphorylation
650	0	4	_aSerum Albumin _xpharmacology
650	0	4	_aSerum Albumin, Human
650	0	4	_aSignal Transduction
700	1		_aZhao, Shanchao
700	1		_aTang, Jing
700	1		_aLi, Zhijie
700	1		_aZhong, Tianyu
700	1		_aLiu, Yawei
700	1		_aChen, Dengyu
700	1		_aZhao, Mingzhe
700	1		_aLi, Yusheng
700	1		_aGong, Xiaowei
700	1		_aDeng, Peng
700	1		_aWang, Jiang H
700	1		_aJiang, Yong
773	0		_tThe FEBS journal _gvol. 276 _gno. 16 _gp. 4598-606
856	4	0	_uhttps://doi.org/10.1111/j.1742-4658.2009.07165.x _zAvailable from publisher's website
999			_c19053137 _d19053137